Annika Haywood

Title: Annika Haywood: Innovator in Cardiomyopathy Diagnostics

Introduction

Annika Haywood is a prominent inventor based in St. John's, Canada. She has made significant contributions to the field of cardiology, particularly in the diagnosis and treatment of cardiomyopathy. With a focus on innovative methods and compositions, her work has the potential to impact many lives.

Latest Patents

Annika Haywood holds 2 patents related to diagnostic tests for cardiomyopathy. Her latest patents describe methods and compositions for diagnosing and treating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). These patents provide methods for screening, diagnosing, or detecting a risk of developing ARVD/C by identifying the presence of a transmembrane protein 43 (TMEM43) disease-associated variant in a subject's sample. The presence of this variant indicates that the subject has ARVD/C or an increased risk of developing the condition compared to individuals with wild-type TMEM43.

Career Highlights

Throughout her career, Annika has worked with notable organizations, including Genesis Group Inc. and Memorial University of Newfoundland. Her experience in these institutions has allowed her to develop her expertise in cardiology and diagnostics.

Collaborations

Annika has collaborated with esteemed colleagues such as Terry-Lynn Young and Kathy Hodgkinson. These partnerships have further enriched her research and innovation in the field.

Conclusion

Annika Haywood is a trailblazer in the realm of cardiomyopathy diagnostics, with her innovative patents paving the way for improved detection and treatment of this serious condition. Her contributions are invaluable to the medical community and will continue to influence future advancements in cardiology.